Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia

NCT07017855 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT07017855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07017855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia
Lead sponsor
Medical University of Silesia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
November 1, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardioverter-defibrillators, implantable, stereotactic body radiation therapy (sbrt), stereotactic radiation, stereotactic techniques, ventricular tachycardia (v-tach), ventricular tachycardia (vt), ventricular tachycardia, monomorphic, ventricular tachycardia, sustained